UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mortality and progression to AIDS after starting highly active antiretroviral therapy

AIDS (London), 2003-10, Vol.17 (15), p.2227-2236

2003

Volltextzugriff (PDF)

No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial

PLoS medicine, 2012-03, Vol.9 (3), p.e1001196-e1001196

2012

Volltextzugriff (PDF)

Integration of HIV and TB services results in improved TB treatment outcomes and earlier prioritized ART initiation in a large urban HIV clinic in Uganda

Journal of acquired immune deficiency syndromes (1999), 2012-06, Vol.60 (2), p.e29-e35

2012

Volltextzugriff (PDF)

Persistent immune activation in HIV-1 infection is associated with progression to AIDS

AIDS (London), 2003-09, Vol.17 (13), p.1881-1888

2003

Volltextzugriff (PDF)

The discovery and development of antiretroviral agents

Antiviral therapy, 2014-01, Vol.19 Suppl 3 (3_suppl), p.5-14

2014

Volltextzugriff (PDF)

Pharmacokinetics and 48-week safety and efficacy of generic lopinavir/ritonavir in Thai HIV-infected patients

Antiviral therapy, 2013-01, Vol.18 (2), p.249-252

2013

Volltextzugriff (PDF)

Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1

PLoS medicine, 2004-10, Vol.1 (1), p.e19-e19

2004

Volltextzugriff (PDF)

Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age

Vaccine, 2012-01, Vol.30 (5), p.904-910

2012

Volltextzugriff (PDF)

Global Response to HIV: Treatment as Prevention, or Treatment for Treatment?

Clinical infectious diseases, 2014-07, Vol.59 (suppl_1), p.S7-S11

2014

Volltextzugriff (PDF)

Advanced liver fibrosis by transient elastography, Fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: Role of vitamin D levels

Journal of gastroenterology and hepatology, 2014-09, Vol.29 (9), p.1706-1714

2014

Volltextzugriff (PDF)

Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in thai HIV-1 infected patients

AIDS (London), 2007-07, Vol.21 (12), p.1535-1539

2007

Volltextzugriff (PDF)

Efavirenz: a review

Expert opinion on pharmacotherapy, 2007-04, Vol.8 (6), p.851-871

2007

Volltextzugriff (PDF)

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort

AIDS (London), 2004-05, Vol.18 (8), p.1169-1177

2004

Volltextzugriff (PDF)

HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy

AIDS (London), 2008-08, Vol.22 (13), p.1583-1588

2008

Volltextzugriff (PDF)

Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001

AIDS (London), 2003-10, Vol.17 (15), p.2191-2199

2003

Volltextzugriff (PDF)

Are adverse events of nevirapine and efavirenz related to plasma concentrations?

Antiviral therapy, 2005-01, Vol.10 (4), p.489-498

2005

Volltextzugriff (PDF)

Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection

PLoS medicine, 2006-11, Vol.3 (11), p.1999-2004

2006

Volltextzugriff (PDF)

Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy

Antiviral therapy, 2014, Vol.19 (1), p.41-49

2014

Volltextzugriff (PDF)

Once-daily highly active antiretroviral therapy for HIV-infected children: safety and efficacy of an efavirenz-containing regimen

Pediatrics (Evanston), 2007-03, Vol.119 (3), p.e705-e715

2007

Volltextzugriff (PDF)

Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting

Antiviral therapy, 2013-01, Vol.18 (4), p.615-622

2013

Volltextzugriff (PDF)

Nevirapine and efavirenz pharmacokinetics and covariate analysis in the 2NN study

Antiviral therapy, 2005, Vol.10 (1), p.145-155

2005

Volltextzugriff (PDF)

We must not let protestors derail trials of pre-exposure prophylaxis for HIV

PLoS medicine, 2005-09, Vol.2 (9), p.e248-e248

Lange, Joep M A

2005

Volltextzugriff (PDF)

Advanced liver fibrosis by transient elastography, F ibrosis 4, and alanine aminotransferase/platelet ratio index among A sian hepatitis C with and without human immunodeficiency virus infection: Role of vitamin D levels

Journal of gastroenterology and hepatology, 2014-09, Vol.29 (9), p.1706-1714

2014

Volltextzugriff (PDF)

Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions

AIDS (London), 2005-07, Vol.19 (11), p.1145-1154

2005

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(78)

Publikationsform

Artikel
(88)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(73)
Humans
(71)
Life Sciences & Biomedicine
(71)
Infectious Diseases
(56)
Hiv Infections - Drug Therapy
(50)
Virology
(48)
Biological And Medical Sciences
(46)
Medical Sciences
(46)
Male
(41)
Female
(38)
Immunology
(36)
Adult
(35)
Antiviral Agents
(35)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(34)
Pharmacology. Drug Treatments
(34)
Aids/hiv
(30)
Human Immunodeficiency Virus
(30)
Human Viral Diseases
(30)
Viral Diseases
(30)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Mortality and progression to AIDS after starting highly active antiretroviral therapy

No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial

Integration of HIV and TB services results in improved TB treatment outcomes and earlier prioritized ART initiation in a large urban HIV clinic in Uganda

Persistent immune activation in HIV-1 infection is associated with progression to AIDS

The discovery and development of antiretroviral agents

Pharmacokinetics and 48-week safety and efficacy of generic lopinavir/ritonavir in Thai HIV-infected patients

Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1

Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age

Global Response to HIV: Treatment as Prevention, or Treatment for Treatment?

Advanced liver fibrosis by transient elastography, Fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: Role of vitamin D levels

Ketoconazole is inferior to ritonavir as an alternative booster for saquinavir in a once daily regimen in thai HIV-1 infected patients

Efavirenz: a review

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort

HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy

A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients

Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001

Are adverse events of nevirapine and efavirenz related to plasma concentrations?

Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection

Decline in serum 25 hydroxyvitamin D levels in HIV-HBV-coinfected patients after long-term antiretroviral therapy

Once-daily highly active antiretroviral therapy for HIV-infected children: safety and efficacy of an efavirenz-containing regimen

Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting

Nevirapine and efavirenz pharmacokinetics and covariate analysis in the 2NN study

We must not let protestors derail trials of pre-exposure prophylaxis for HIV

Advanced liver fibrosis by transient elastography, F ibrosis 4, and alanine aminotransferase/platelet ratio index among A sian hepatitis C with and without human immunodeficiency virus infection: Role of vitamin D levels

Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions

Suchergebnisse filtern